Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans

Lena Brydon, Cicely Walker, Andrew Wawrzyniak, Daisy Whitehead, Hisayoshi Okamura, Jumpei Yajima, Akira Tsuda, Andrew Steptoe, Lena Brydon, Cicely Walker, Andrew Wawrzyniak, Daisy Whitehead, Hisayoshi Okamura, Jumpei Yajima, Akira Tsuda, Andrew Steptoe

Abstract

Activation of the innate immune system is commonly accompanied by a set of behavioural, psychological and physiological changes known as 'sickness behaviour'. In animals, infection-related sickness symptoms are significantly increased by exposure to psychosocial stress, suggesting that psychological and immune stressors may operate through similar pathways to induce sickness. We used a double-blind, randomised, placebo-controlled design to examine the effect of acute psychological stress on immune and subjective mood responses to typhoid vaccination in 59 men. Volunteers were assigned to one of four experimental conditions in which they were either injected with typhoid vaccine or saline placebo, and then either rested or completed two challenging behavioural tasks. Typhoid vaccine induced a significant rise in participants' serum levels of interleukin-6 (IL-6) and this response was significantly larger in the stress versus rest conditions. Negative mood increased immediately post-tasks, an effect also more pronounced in the vaccine/stress condition. In the vaccine/stress group, participants with larger IL-6 responses had heightened systolic blood pressure responses to tasks and elevated post-stress salivary levels of the noradrenaline metabolite 3-methoxy-phenyl glycol (MHPG) and cortisol. Our findings suggest that, as seen in animals, psychological and immune stressors may act synergistically to promote inflammation and sickness behaviour in humans.

Figures

Fig. 1
Fig. 1
Subjective stress ratings at baseline (Base), during each of the tasks (Stroop, Speech) and at 30, 60 and 120 min post-tasks. Comparison of stress (solid lines) and rest (dotted lines) conditions in participants receiving typhoid vaccine (circles) or saline placebo (squares). Data are presented as means ± SEM.
Fig. 2
Fig. 2
Systolic blood pressure (A), diastolic blood pressure (B), and heart rate (C) at baseline (Base), during each of the tasks (Stroop, Speech) and at 25–30, 55–60 and 115–120 min post-tasks. Comparison of stress (solid lines) and rest (dotted lines) conditions in participants receiving typhoid vaccine (circles) or saline placebo (squares). Data are presented as means ± SEM.
Fig. 3
Fig. 3
Salivary 3-methoxy-phenylglycol (MHPG) concentrations before (Base), immediately following tasks (post-task) and at 15, 30, 60 and 120 min post-tasks. Comparison of MHPG stress responses in participants receiving typhoid vaccine (circles) or saline placebo (squares). MHPG was assessed using gas chromatography mass spectrometry. Distributions of MHPG were skewed, so were log transformed prior to analyses. Data are presented as log means ± SEM.
Fig. 4
Fig. 4
Serum interleukin-6 (IL-6) concentrations before (Base) and 120 min post-tasks (120 min post-task). Comparison of stress (solid lines) and rest (dotted lines) conditions in participants receiving typhoid vaccine (circles) or saline placebo (squares). IL-6 was measured using a high-sensitivity two-site ELISA. Distributions of IL-6 were skewed, so were log transformed prior to analyses. Data are presented as log means ± SEM.
Fig. 5
Fig. 5
Total negative mood scores at baseline (Base), immediately following tasks (post-task) and at 30, 60 and 120 min post-tasks. Comparison of stress (solid lines) and rest (dotted lines) conditions in participants receiving typhoid vaccine (circles) or saline placebo (squares). Data are presented as means ± SEM.
Fig. 6
Fig. 6
Scatter plot illustrating the relationship between systolic blood pressure responses to the Speech task and changes in serum interleukin-6 (IL-6) levels, in the vaccine/stress group.

References

    1. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain–immune interactions. Ann. Med. 2003;35:2–11.
    1. Anisman H., Poulter M.O., Gandhi R., Merali Z., Hayley S. Interferon-α effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J. Neuroimmunol. 2007;186:45–53.
    1. Black P.H., Garbutt L.D. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 2002;52:1–23.
    1. Broug-Holub E., Persoons J.H., Schornagel K., Mastbergen S.C., Kraal G. Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am. J. Respir. Cell Mol. Biol. 1998;19:842–848.
    1. Brydon L., Edwards S., Mohamed-Ali V., Steptoe A. Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav. Immun. 2004;18:281–290.
    1. Brydon L., Edwards S., Jia H., Mohamed-Ali V., Zachary I., Martin J.F., Steptoe A. Psychological stress activates interleukin-1β gene expression in human mononuclear cells. Brain Behav. Immun. 2005;19:540–546.
    1. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon-α. Biol. Psychiatry. 2004;56:819–824.
    1. Dantzer R., Bluthe R.M., Castanon N., Kelly K.W., Konsman J.-P., Laye S., Lestage J., Parnet P. Cytokines, sickness behavior, and depression. In: Ader R., editor. Psychoneuroimmunology. Elsevier; New York: 2007. pp. 281–318.
    1. Dantzer R., O’Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56.
    1. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095–2147.
    1. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 2006;6:52–68.
    1. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., Nemeroff C.B., Bremner J.D., Carney R.M., Coyne J.C., DeLong M.R., Frasure-Smith N., Glassman A.H., Gold P.W., Grant I., Gwyther L., Ironson G., Johnson R.L., Kanner A.M., Katon W.J., Kaufmann P.G., Keefe F.J., Ketter T., Laughren T.P., Leserman J., Lyketsos C.G., McDonald W.M., McEwen B.S., Miller A.H., Musselman D., O’Connor C., Petitto J.M., Pollock B.G., Robinson R.G., Roose S.P., Rowland J., Sheline Y., Sheps D.S., Simon G., Spiegel D., Stunkard A., Sunderland T., Tibbits P., Jr., Valvo W.J. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry. 2005;58:175–189.
    1. Gandhi R., Hayley S., Gibb J., Merali Z., Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav. Immun. 2007;21:477–489.
    1. Gibb J., Hayley S., Gandhi R., Poulter M.O., Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav. Immun. 2008;22:573–589.
    1. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988;12:123–137.
    1. Hayley S., Poulter M.O., Merali Z., Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005;135:659–678.
    1. Hingorani A.D., Cross J., Kharbanda R.K., Mullen M.J., Bhagat K., Taylor M., Donald A.E., Palacios M., Griffin G.E., Deanfield J.E., MacAllister R.J., Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994–999.
    1. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 2007;21:374–383.
    1. Johnson J.D., Campisi J., Sharkey C.M., Kennedy S.L., Nickerson M., Greenwood B.N., Fleshner M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005;135:1295–1307.
    1. Johnson J.D., O’Connor K.A., Deak T., Stark M., Watkins L.R., Maier S.F. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 2002;16:461–476.
    1. Kemeny M.E., Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav. Immun. 2007;21:1009–1018.
    1. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry. 1999;156:837–841.
    1. Krabbe K.S., Reichenberg A., Yirmiya R., Smed A., Pedersen B.K., Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav. Immun. 2005;19:453–460.
    1. Lenczowski M.J., Bluthe R.M., Roth J., Rees G.S., Rushforth D.A., van Dam A.M., Tilders F.J., Dantzer R., Rothwell N.J., Luheshi G.N. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am. J. Physiol. 1999;276:R652–R658.
    1. Lesperance F., Frasure-Smith N., Theroux P., Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry. 2004;161:271–277.
    1. McNair, D. M., Lorr, N., Droppleman, L. F., 1981. Manual for the Profile of Mood States
    1. Merali Z., Lacosta S., Anisman H. Effects of interleukin-1β and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. 1997;761:225–235.
    1. Mohamed-Ali V., Flower L., Sethi J., Hotamisligil G., Gray R., Humphries S.E., York D.A., Pinkney J. β-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 2001;86:5864–5869.
    1. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007;7:161–167.
    1. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31.
    1. Reuster T., Rilke O., Oehler J. High correlation between salivary MHPG and CSF MHPG. Psychopharmacol. (Berl) 2002;162:415–418.
    1. Simmons D.A., Broderick P.A. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:793–807.
    1. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 1999;88:823–836.
    1. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007;21:901–912.
    1. Strike P.C., Wardle J., Steptoe A. Mild acute inflammatory stimulation induces transient negative mood. J. Psychosom. Res. 2004;57:189–194.
    1. von Kanel R., Kudielka B.M., Preckel D., Hanebuth D., Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav.Immun. 2006;20:40–48.
    1. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 2005;19:345–350.
    1. Yang R.K., Yehuda R., Holland D.D., Knott P.J. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Biol. Psychiatry. 1997;42:821–826.
    1. Yajima J., Tsuda A., Yamada S., Tanaka M. Determination of saliva free-3-methoxy-4-hydroxyphenylglycol in normal volunteers using gas chromatography mass spectrometry. Biogenic Amines. 2001;16:173–183.
    1. Zautra A.J., Yocum D.C., Villanueva I., Smith B., Davis M.C., Attrep J., Irwin M. Immune activation and depression in women with rheumatoid arthritis. J. Rheumatol. 2004;31:457–463.

Source: PubMed

3
구독하다